WVXU: New heart program from UC scientist is keeping South Asians across U.S. healthy
Red Saree reaches community with outreach and education
Research shows South Asians are four times more likely to develop heart disease than the rest of the population. One University of Cincinnati scientist is moving beyond genetics to talk about risk and prevention. In the midst of collecting saliva for one of his studies, Satkthivel Sadayappan, PhD, professor and director of heart research in the UC Heart, Lung and Vascular Institute, realized the South Asian community needed a greater awareness of its risk for heart disease, and a list of preventative measures to save lives.
The solution? Red Saree an awareness campaign he started in Cincinnati in 2018 and it is now spreading across the country. Chapters include Boston, San Francisco, Detroit and Chicago.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.